Skip to main content

D. E. Shaw & Co., Inc.

Position in AMLX — Amylyx Pharmaceuticals, Inc.

CIK 1009207 New York, NY

Position in AMLX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,031,796
+$147,251 QoQ
Shares Held
74,230
+1.4% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in AMLX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $613,305,594 across 42 Drug Manufacturers - Specialty & Generic names. AMLX ranks #35 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in AMLX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,031,796 74,230
2025-12-31 $884,545 73,224
2025-09-30 $936,038 68,877
2025-06-30 $971,127 151,502
2025-03-31 $955,821 270,006
2024-12-31 $1,159,492 306,744
2024-09-30 $2,239,053 691,066
2024-06-30 $2,485,543 1,308,181
2024-03-31 $2,960,935 1,042,583
2023-12-31 $8,051,324 546,965
2023-09-30 $13,920,908 760,290
2023-06-30 $34,297,248 1,590,044
2023-03-31 $59,336,335 2,022,370
2022-12-31 $51,128,897 1,383,732
2022-09-30 $4,567,759 162,265